SCHEMBL12008442

SCHEMBL12008442

CCOc1ccccc1/C=C1\SC(=S)N(CCC(=O)O)C1=O

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARG P37231 2/20 0.75
▸ POLB P06746 3/20 0.70
▸ CTNNB1 P35222 1/20 0.70
▸ TCF7L2 Q9NQB0 1/20 0.70
▸ MAPT P10636 2/20 0.67
▸ NCOA3 Q9Y6Q9 2/20 0.67
▸ MITF O75030 1/20 0.67
▸ RAB9A P51151 1/20 0.67
▸ FABP4 P15090 1/20 0.67
▸ CISD1 Q9NZ45 2/20 0.65
▸ MAOA P21397 1/20 0.65
▸ TAS2R14 Q9NYV8 1/20 0.64
▸ P2RX3 P56373 1/20 0.61
▸ PSD A5PKW4 1/20 0.61
▸ AKR1B1 P15121 2/20 0.59
▸ KMT2A Q03164 4/20 0.59
▸ MEN1 O00255 3/20 0.59
▸ APAF1 O14727 1/20 0.58
▸ ADAMTS5 Q9UNA0 1/20 0.58
▸ ALDH1A1 P00352 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12008455 0.94 POLB (0.80) PPARGPOLBCTNNB1TCF7L2MAPT
SCHEMBL12008494 0.93 PPARG (0.74) PPARGPOLBCTNNB1TCF7L2MAPT
SCHEMBL6883788 0.90 PPARG (0.74) PPARGPOLBCTNNB1TCF7L2MAPT
SCHEMBL12008756 0.89 CTNNB1 (0.82) PPARGPOLBCTNNB1TCF7L2MAPT
SCHEMBL12008443 0.88 POLB (0.89) PPARGPOLBCTNNB1TCF7L2NCOA3
SCHEMBL12008498 0.88 PPARG (0.70) PPARGPOLBCTNNB1TCF7L2MAPT
SCHEMBL12008776 0.87 MAPT (0.73) PPARGPOLBCTNNB1TCF7L2MAPT
SCHEMBL12008535 0.86 CTNNB1 (0.68) PPARGPOLBCTNNB1TCF7L2MAPT
SCHEMBL30378479 0.86 PPARG (1.00) PPARGPOLBCTNNB1TCF7L2NCOA3
SCHEMBL12008499 0.86 PPARG (1.00) PPARGPOLBCTNNB1TCF7L2NCOA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170049751-A1 OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF DASGUPTA RAMANUJ (US) 2017-02-23 — — US disclosed
US-20170049751-A1 OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF DASGUPTA RAMANUJ (US) 2017-02-23 — — US disclosed
US-9433611-B2 Oxazole and thiazole compounds as β-catenin modulators and uses thereof NEW YORK UNIVERSITY (US) 2016-09-06 — — US disclosed
US-9433611-B2 Oxazole and thiazole compounds as β-catenin modulators and uses thereof NEW YORK UNIVERSITY (US) 2016-09-06 — — US disclosed
US-9173871-B2 Oxazole and thiazole compounds as beta-catenin modulators and uses thereof NEW YORK UNIVERSITY (US) 2015-11-03 — — US disclosed
US-9173871-B2 Oxazole and thiazole compounds as beta-catenin modulators and uses thereof NEW YORK UNIVERSITY (US) 2015-11-03 — — US disclosed
US-20130109675-A1 OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF NEW YORK UNIVERSITY 2013-05-02 — — US disclosed
US-20130109675-A1 OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF NEW YORK UNIVERSITY 2013-05-02 — — US disclosed
US-20120264744-A1 OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF UNITED STATES GOVERNMENT 2012-10-18 — — US disclosed
US-20120264744-A1 OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF UNITED STATES GOVERNMENT 2012-10-18 — — US disclosed
US-8252823-B2 Oxazole and thiazole compounds as beta-catenin modulators and uses thereof NEW YORK UNIVERSITY (US) 2012-08-28 — — US disclosed
US-8252823-B2 Oxazole and thiazole compounds as beta-catenin modulators and uses thereof NEW YORK UNIVERSITY (US) 2012-08-28 — — US disclosed
US-20090227624-A1 Oxazole and thiazole compounds as beta-catenin modulators and uses thereof US ARMY, SECRETARY OF THE ARMY 2009-09-10 — — US disclosed
US-20090227624-A1 Oxazole and thiazole compounds as beta-catenin modulators and uses thereof US ARMY, SECRETARY OF THE ARMY 2009-09-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120264744-A1 OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF CTNNB1, CTNNA1, CTNNBL1 PPARG 295/4885POLB 2397/4885CTNNB1 1/4885
US-20090227624-A1 Oxazole and thiazole compounds as beta-catenin modulators and uses thereof CTNNB1, CTNNA1, CTNNBL1 PPARG 152/4885POLB 2088/4885CTNNB1 1/4885
US-20170049751-A1 OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF CTNNB1, CTNNA1, CTNNBL1 PPARG 152/4885POLB 2088/4885CTNNB1 1/4885
US-20130109675-A1 OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF CTNNB1, CTNNA1, CTNNBL1 PPARG 152/4885POLB 2088/4885CTNNB1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback